Document Detail


Hemodynamic effect of amrinone depends on pretreatment vascular resistance in patients with evolving congestive heart failure: correlation between vascular resistance and neurohormonal activity.
MedLine Citation:
PMID:  9456281     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We investigated the hemodynamic effects of amrinone and assessed its effects on neurohormonal factors in 15 patients with evolving congestive heart failure with various origins. We serially determined the pulmonary and systemic vascular-resistance indices after amrinone infusion and examined the relation between changes in hemodynamic parameters and changes in concentrations of norepinephrine, atrial natriuretic peptide, angiotensin II, and endothelin-1 in the pulmonary capillary wedge region (PCWR) and in the peripheral veins. Amrinone significantly reduced pulmonary vascular-resistance index (PVRI; Wood x m2) in patients with high PVRI (> or =15) before the infusion, significantly reduced systemic vascular-resistance index (SVRI; Wood x m2) in patients with high SVRI (> or =50) before the infusion, and had little effect on vascular resistances in patients with low PVRI (<15) and low SVRI (<50). The reduction in PVRI was correlated with the reduction in the endothelin-1 level (r = 0.75) in the PCWR, and the reduction in SVRI with norepinephrine level (r = 0.70) in the peripheral veins. The angiotensin II level did not change throughout the study. These findings suggest that amrinone had selective hemodynamic effects on pulmonary and systemic circulations with neurohormonal effects, according to PVRI and SVRI before infusion.
Authors:
T Sasaki; S Tomimoto; T Noguchi; T Baba; K Komamura; F Ohmori; K Miyatake
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  31     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  1998 Jan 
Date Detail:
Created Date:  1998-02-12     Completed Date:  1998-02-12     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  80-4     Citation Subset:  IM    
Affiliation:
Division of Cardiology, National Cardiovascular Center, Suita-city, Osaka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Amrinone / therapeutic use*
Angiotensin II / metabolism
Biological Markers
Cardiotonic Agents / therapeutic use*
Endothelin-1 / metabolism
Female
Heart Failure / metabolism*,  physiopathology,  prevention & control*
Hemodynamics / drug effects*
Humans
Male
Norepinephrine / metabolism
Statistics as Topic
Vascular Resistance / drug effects*,  physiology
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Cardiotonic Agents; 0/Endothelin-1; 11128-99-7/Angiotensin II; 51-41-2/Norepinephrine; 60719-84-8/Amrinone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model...
Next Document:  Hemodynamic profile of SKP-450, a new potassium-channel activator.